Eliquis (apixaban) Bleeding Investigation

Eliquis (apixaban) Bleeding Investigation Hero Image

Eliquis May Cause Serious, Irreversible Internal Bleeding

It is believed that Eliquis, also known as apixaban, may put patients at risk for serious bleeding events. Unlike the older anticoagulant warfarin, the effects of which can be reversed with common treatments such as Vitamin K, the maker of Eliquis has yet to develop an antidote to reverse the drug’s blood-thinning effects.

It has been alleged that due to the drug’s lack of an antidote, doctors are unable to properly intervene and treat Eliquis patients during serious bleeding events. This can lead to:

  • Gastrointestinal (GI) bleeding
  • Rectal bleeding
  • Kidney bleeding
  • Cerebral hemorrhages
  • Death

Lawsuits Allege Other New Blood Thinners Are Dangerous and Defective

Xarelto and Pradaxa, new blood thinners that are similar to Eliquis, have previously been targeted in lawsuits alleging that the drugs are dangerous and defective. While the maker of Pradaxa has since settled the thousands of lawsuits it faced, the company that manufactures Xarelto continues to be targeted in hundreds of cases filed by both victims and those who lost loved ones to Xarelto-related injuries.

These lawsuits allege that the makers of Xarelto failed to adequately warn patients and doctors that no reversal agent exists to stop the blood-thinning effects of their drug. Therefore, the plaintiffs allege that doctors had no means of treating patients who took Xarelto in the event of a bleed, which resulted in serious and fatal internal bleeding complications.